HIF1A and neoplasm: The increased miR-21-5p subsequently degrades its downstream HIF-1αN (a HIF-1α subunit inhibitor) by targeting its 3′-UTR, leading to the activation of the tumor-promoting HIF-1α/VEGF pathway [49].